WOLFGANG WINKELMAYER to Quality-Adjusted Life Years
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Quality-Adjusted Life Years.
Connection Strength
0.258
-
Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant. 2012 Jan; 27(1):429-34.
Score: 0.091
-
The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
Score: 0.088
-
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
Score: 0.050
-
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis. Pharmacoeconomics. 2007; 25(11):949-61.
Score: 0.017
-
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int. 2003 Jul; 64(1):295-304.
Score: 0.013